RUTABAGA CAPITAL MANAGEMENT LLC/MA - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 182 filers reported holding HAEMONETICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RUTABAGA CAPITAL MANAGEMENT LLC/MA ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2017$10,395,000
+2.5%
178,976
-20.8%
2.39%
+10.5%
Q3 2017$10,144,000
-42.1%
226,076
-49.0%
2.16%
-33.9%
Q2 2017$17,505,000
-12.6%
443,269
-10.2%
3.27%
-1.9%
Q1 2017$20,018,000
-3.0%
493,419
-3.9%
3.33%
-5.9%
Q4 2016$20,647,000
+10.0%
513,619
-0.9%
3.54%
-0.1%
Q3 2016$18,774,000
+5.4%
518,487
-15.6%
3.55%
+6.8%
Q2 2016$17,805,000614,1873.32%
Other shareholders
HAEMONETICS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders